
Michewa Pharma Private Limited
About Michewa Pharma Private Limited
Data last updated:
Michewa Pharma Private Limited is a private limited company based in Delhi, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 04 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U36996DL2016PTC299062. Its GSTIN is 07AAKCM3066B1ZO (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Bavita Sharma and Atul Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 113 1st Floor Omega Mall Cs/Ocf Sector 25 Rohini New Delhi 110085, Delhi, India – 110085.
As per the financials filed for FY 2024, the company reported a revenue of ₹21.12 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹11.6 Lakh (net margin 54.9%) and EBITDA of ₹15.46 Lakh (EBITDA margin 73.2%). Revenue has grown at a compounded annual rate (CAGR) of 152% over three years and 38% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Michewa Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No. 113 1st Floor Omega Mall Cs/Ocf Sector 25 Rohini New Delhi 110085, Delhi, India – 110085
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Michewa Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Michewa Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Michewa Pharma Private Limited, buy the company report.
Financials of Michewa Pharma Private Limited
FY 2025 filings availableMichewa Pharma Private Limited reported revenue of ₹21.12 Lakh (up 597% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 38% over five years, including 597% growth in the latest year. EBITDA rose 614% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.46 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.6 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 73.2% | ||||
| Net Profit Margin | 54.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Michewa Pharma Private Limited, buy the company report.
Board of directors of Michewa Pharma Private Limited
Michewa Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bavita Sharma | Director | 17 Mar 2020 | 6 Years 8 Months | Current |
| Atul Sharma | Director | 04 May 2016 | 10 Years 6 Months | Current |
Peer comparison
Michewa Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bhagya Lakshmi Laboratories Limited | ₹21.16 Lakh (FY 2023) | -78.0% | Mumbai, Maharashtra, India | |||
| Inpravet Healthcare India Private Limited | ₹21.16 Lakh (FY 2025) | -34.0% | Patna, Bihar, India | |||
| Kayra Corporation Private Limited | ₹21.15 Lakh (FY 2024) | Gandhinagar, Gujarat, India | ||||
| Agam and Gem Laboratories Private Limited | ₹21.15 Lakh (FY 2024) | -54.0% | Daman, Daman and Diu, India | |||
| Phool Chand Herbals Private Limited | ₹21.14 Lakh (FY 2025) | 0.0% | Roorkee, Uttarakhand, India | |||
| Michewa Pharma Private Limitedthis company | ₹21.12 Lakh (FY 2024) | ₹11.6 Lakh | 54.9% | 597.0% | Delhi, India | |
| MRC Chemicals Private Limited | ₹21.11 Lakh (FY 2025) | -5.0% | Darbhanga, Bihar, India | |||
| Pole-Star Medichem Private Limited | ₹21.1 Lakh (FY 2024) | -15.0% | Chennai, Tamil Nadu, India | |||
| Emepearl Health Private Limited | ₹21.08 Lakh (FY 2021) | 33.0% | Chennai, Tamil Nadu, India | |||
| Earthgetz Life Science Private Limited | ₹21.08 Lakh (FY 2025) | 412.0% | Kalol, Gujarat, India | |||
| Smhec Smasco Healthcare (OPC) Private Limited | ₹21.05 Lakh (FY 2024) | -27.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Michewa Pharma Private Limited, buy the company report.
Auditor
Michewa Pharma Private Limited is audited by Rajendra K. Goel & Co. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Rajendra K. Goel & Co. | FY 2017 | FRN 001457N |
Shareholding
The shareholding of Michewa Pharma Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Michewa Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Michewa Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Michewa Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Michewa Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAKCM3066B1ZO | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Michewa Pharma Private Limited, buy the company report.
Recent activity
Michewa Pharma Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Bavita Sharma ceased to be Additional Director on 31 Dec 2020.
Frequently asked questions
Michewa Pharma is an active private limited company based in Delhi, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 04 May 2016 (10+ years old) and is registered under CIN U36996DL2016PTC299062.
Michewa Pharma has 2 current directors:
- Bavita Sharma - Director
- Atul Sharma - Director
The latest financial statements of Michewa Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Michewa Pharma is 07AAKCM3066B1ZO, registered in Delhi.
The CIN (Corporate Identification Number) of Michewa Pharma is U36996DL2016PTC299062. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Michewa Pharma was incorporated on 04 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Michewa Pharma by revenue are Bhagya Lakshmi Laboratories Limited, Inpravet Healthcare India Private Limited, Kayra Corporation Private Limited, Agam and Gem Laboratories Private Limited, Phool Chand Herbals Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bavita Sharma ceased to be Additional Director on 31 Dec 2020. Bavita Sharma was appointed as Director on 17 Mar 2020. Tara Dutt Sharma ceased to be Director on 01 Feb 2020. Michewa Pharma has 4 board changes on record in total.
The registered office of Michewa Pharma is at Shop No. 113 1st Floor Omega Mall CsOcf Sector 25 Rohini New Delhi 110085, Delhi, India – 110085.
Michewa Pharma operates in the chemicals industry, in the medicinal chemical and botanical products segment.
The compliance status of Michewa Pharma is compliant as of 18 August 2026. The company is actively filing with the Registrar of Companies.

